Enaleni Pharmaceuticals Limited - Dealing In Secur
ENL
ENL
Enaleni Pharmaceuticals Limited - Dealing In Securities By Directors
Enaleni Pharmaceuticals Limited
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(JSE code: ENL & ISIN: ZAE000067740)
("Enaleni" or "the company")
DEALING IN SECURITIES BY DIRECTORS
In terms of paragraph 3.63 - 3.65 of the JSE Limited Listings Requirements, the
following information, relating to the sale of ordinary shares on the open
market by Chris Aucamp, an executive director of Cipla Medpro, a major
subsidiary of Enaleni, is disclosed as follows:
Date of transaction : 25 April 2006
Number of shares : 28 029
Price : 420,22 cents per share
Value of transaction : R117 783,46
Date of transaction : 26 April 2006
Number of shares : 250 000
Price : 420 cents per share
Value of transaction : R1 050 000
Date of transaction : 28 April 2006
Number of shares : 54 240
Price : 424,48 cents per share
Value of transaction : R230 237,95
Extent of interest : Indirect non-beneficial
Written clearance to
deal obtained : Yes
Johannesburg
2 May 2006
Date: 02/05/2006 05:45:03 PM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
